33-104 : Drug Use-Results Survey of OPDIVO
Not Applicable
- Conditions
- nresectable advanced/recurrent malignant pleural mesothelioma that has progressed after cancer chem
- Registration Number
- JPRN-jRCT2011230029
- Lead Sponsor
- Kuro Toshihiko
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Patients with unresectable advanced/recurrent malignant pleural mesothelioma that has progressed after cancer chemotherapy, who have recieved OPDIVO for the first time
Exclusion Criteria
Patients who have received OPDIVO previously
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method [Safety]<br>a) Occurrence status of adverse drug reactions and infections, <br>b) Factors that are considered to affect safety<br>c) Adverse events
- Secondary Outcome Measures
Name Time Method